• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Merck`s WELIREG® Gets EU Nod For VHL Tumors & Advanced RCC

    BUSINESSWIRE

    Exelixis And Merck Sign Clinical Development Collaboration

    BUSINESSWIRE

    HiberCell: First Patient Dosed In Merck Combo Trial For ccRCC

    GLOBENEWSWIRE

    US FDA approves Merck`s drug for kidney cancer

    REUTERS

    At ESMO, Merck touts Welireg`s potential in kidney cancer

    FIERCE PHARMA

    Merck’s WELIREG Improved Objective Response Rates Versus Everolimus in RCC

    BUSINESSWIRE

    FDA Accepts for Priority Review Merck’s Supplemental NDA for WELIREG

    BUSINESSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.